10 Dec 2018
New immunotherapy improves MS symptoms
A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis has improved symptoms and quality of life for the majority of patients.
26 Nov 2018
PrEP trial leads to unprecedented reductions in HIV transmission
Recent HIV infections in gay and bisexual men in New South Wales have declined by almost one-third following the trial of an HIV prevention medication…
22 Nov 2018
Rethinking control of Australia’s most common STI
Australia's most common sexually transmitted infection, chlamydia, is unlikely to be eliminated by opportunistic testing in general practice.
14 Nov 2018
Development of antibacterial surfaces for bone implants
A University of Sydney team in collaboration with the University Medical Centre Utrecht has found a solution to the infection-related rejection of implants, including knees…
13 Nov 2018
Hepatitis C treatment effective for people who inject drugs
Researchers from the Kirby Institute say its time to remove restrictions that prevent recent drug users from accessing successful hepatitis C treatment.
09 Nov 2018
Prevention of HIV increasing, but no one should be left behind
Gay and bisexual men are getting tested and using medications to prevent HIV transmission more than ever.
08 Nov 2018
Anti-cancer drugs may hold key to overcoming antimalarial drug resistance
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines.
05 Nov 2018
It’s time to act to reduce diabetes-related foot disease
Greater investment from governments, health professionals and researchers is needed to reduce costly and common diabetes-related foot disease (DFD).
03 Nov 2018
New class of antibiotics gives hope for treating multi-drug resistant bacteria
The rapid spread of multidrug-resistant bacteria is a global health emergency, and in the absence of new drugs it is widely reported that common infections…